Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Grant/Award of 60,833 ELTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 60,833 | n/a |
| Feb 3, 2026 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 24,000 | n/a |
| Apr 16, 2025 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 191,624 | n/a |
| Oct 2, 2024 | Cidara Therapeutics, Inc. (CDTX) | Grant/Award | 130,087 | n/a |
| Mar 20, 2024 | Cidara Therapeutics, Inc. (CDTX) | Grant/Award | 108,750 | n/a |
| Mar 12, 2024 | Cidara Therapeutics, Inc. (CDTX) | Sale | 18,931 | $12.7K |
| Mar 29, 2023 | Cidara Therapeutics, Inc. (CDTX) | Grant/Award | 90,000 | n/a |
| Mar 14, 2023 | Cidara Therapeutics, Inc. (CDTX) | Sale | 6,648 | $10.2K |
| Sep 20, 2022 | Cidara Therapeutics, Inc. (CDTX) | Exercise/Conversion | 50,000 | n/a |
| Apr 4, 2022 | Cidara Therapeutics, Inc. (CDTX) | Grant/Award | 51,250 | n/a |